AMERICAN JOURNAL OF CLINICAL NUTRITION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2024-08-20 ms2000001187604097 来自湖南省

没有with editor这一步，Under Review是编辑内审，已被拒

90 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2023-07-28 ms6000001130815798 来自江苏省

投过两次，都是第二天变under review，效率极高

231 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2023-10-27 ms6000000972355471 来自黑龙江省

偏重的研究方向：营养流行病学
经验分享：投过一次,Under Review是送外审了吗

235 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2022-08-29 ms1000000037335282

想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？

236 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2023-07-30 ZY2021 来自山西省

大家好，这个杂志收版面费吗？大概多少？

239 0

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2020-05-22 1258faf6m29暂无昵称

效率极高，审稿严格，前后4个月

820 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2022-03-29 fengxiuming

投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。

265 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2023-02-15 做梦也想sci 来自山东省

偏重的研究方向：外科;术后营养
经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT

244 0

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2022-08-25 ms1000001687207454

审稿速度:1.0
经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？

211 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221481, encodeId=94f2222148150, content=没有with editor这一步，Under Review是编辑内审，已被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Tue Aug 20 10:46:31 CST 2024, time=2024-08-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2150243, encodeId=c5b92150243fb, content=投过两次，都是第二天变under review，效率极高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d4c8628089, createdName=ms6000001130815798, createdTime=Fri Jul 28 12:05:48 CST 2023, time=2023-07-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2165217, encodeId=a0c0216521eaf, content=偏重的研究方向：营养流行病学 经验分享：投过一次,Under Review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f99d5553602, createdName=ms6000000972355471, createdTime=Fri Oct 27 12:46:29 CST 2023, time=2023-10-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1241885, encodeId=376c12418853f, content=想问下大家，很快decision drafted 是什么意思啊，要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8436390978, createdName=ms1000000037335282, createdTime=Mon Aug 29 19:40:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150492, encodeId=39c3215049210, content=大家好，这个杂志收版面费吗？大概多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11465538025, createdName=ZY2021, createdTime=Sun Jul 30 10:35:05 CST 2023, time=2023-07-30, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=591504, encodeId=f0915915046d, content=效率极高，审稿严格，前后4个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=820, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1258faf6m29暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207037, encodeId=e88e120e0377d, content=投了这个杂志需要各个作者确认相关信息的吗？我看见投稿系统提交手稿之后有一个authors status的选项，点进去看了是各个作者，显示的是no reponse，但是重发信息到相应邮箱又没有看到有要确认作者的链接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fa45328678, createdName=fengxiuming, createdTime=Tue Mar 29 22:43:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114684, encodeId=d431211468400, content=偏重的研究方向：外科;术后营养 经验分享：请问各位前辈这个期刊不承认在中国临床试验注册中心网站注册的课题吗？试验已经做完了没法再在clinicaltrials.gov上再注册了，这咋办。。。ToT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Wed Feb 15 09:06:42 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1240887, encodeId=063c124088e83, content=审稿速度:1.0 经验分享：请问各位大佬，投这个期刊，显示的状态为Decision Drafted，请问这是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=229d5592672, createdName=ms1000001687207454, createdTime=Thu Aug 25 10:24:30 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067867, encodeId=9d1e106e8676c, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e785486640, createdName=huichen9, createdTime=Sun Nov 07 18:31:21 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2021-11-07 huichen9

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：营养
经验分享：审稿人很严格，提了很多意见 2020.6.22投 2020.8.14大修 2020.9.11收

456 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务